证券代码：601886 证券简称：江河集团 公告编号：2023-029 江河创建集团股份有限公司 召开的日期时间：2023 年 9 月 18 日 14 点 30 分 召开地点：北京市顺义区顺西南路艾迪公园 5 号楼一层贵宾室 (五) 网络投票的系统、起止日期和投票时间。 股东大会召开日期：2023年9月18日 本次股东大会采用的网络投票系统：上海证券交易所股东大会网络投票 系统 关于召开 2023 年第一次临时股东大会的通知 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 一、 召开会议的基本情况 (一) 股东大会类型和届次 2023 年第一次临时股东大会 (二) 股东大会召集人：董事会 (三) 投票方式：本次股东大会所采用的表决方式是现场投票和网络投票相结 合的方式 (四) 现场会议召开的日期、时间和地点 网络投票系统：上海证券交易所股东大会网络投票系统 网络投票起止时间：自 2023 年 9 月 18 日 至 2023 年 9 月 18 日 采用上海证券交易所网络投票系统，通过交易系统投票平台的投票时间为股 ...

江河创建集团股份有限公司 独立董事关于公司全资子公司对外提供阶段性担保的 独立意见 根据《上市公司监管指引第 8 号——上市公司资金往来、对外担保的监管要 求》、《上海证券交易所股票上市规则》及《公司章程》等有关规定，我们作为江 河创建集团股份有限公司（以下简称"公司"）独立董事对公司的对外担保事项 进行了认真审核，特作如下说明并发表独立意见： 我们认为：按照金融机构贷款政策和房地产行业的商业惯例，同意广州子公 司为买方提供阶段性连带责任保证担保，担保金额合计不超过人民币 6 亿元，担 保期限自担保合同生效且贷款发放之日起至买方取得房产权属证书且抵押登记 手续办理完毕之日止。该阶段性担保事项符合公司的经营发展需要，对公司正常 经营不构成重大影响，不存在损害公司利益及全体股东利益的情形。本次议案的 审议和表决程序符合相关法律法规及《公司章程》等规定。我们同意将该议案提 交公司股东大会审议，同意董事会提请股东大会授权公司董事长或董事长指定人 员在上述担保额度内办理担保相关手续，并签署相关法律文件。 特此确认。 （以下无正文） (本页无正文,为江河创建集团股份有限公司独立董事之独立意见签字页) 独立董事签字: 朱 ...

表决情况：9票同意，0票反对，0票弃权。 同意公司全资子公司广州江河幕墙制造有限公司为银行认可并购买绿色建筑 智能制造产业基地部分分割销售厂房的按揭贷款客户提供阶段性担保，担保总额 不超过人民币6亿元,担保期限自担保合同生效且贷款发放之日起至买方取得房产 权属证书且抵押登记手续办理完毕之日止。 江河创建集团股份有限公司 第六届董事会第十次会议决议公告 本公司及董事会全体成员保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实、准确和完整承担个别及连带责任。 2023年9月1日，江河创建集团股份有限公司（以下简称"公司"）第六届董事 会第十次会议以现场和通讯方式召开。会议通知已通过专人送达、邮件等方式送 达给董事，会议应到董事9人，实到董事9人，公司监事、部分高级管理人员及相 关人员列席会议，符合《公司法》及《公司章程》规定。会议由公司董事长刘载 望先生主持，经过讨论，一致同意通过如下决议： 一、通过《关于公司全资子公司对外提供阶段性担保的议案》。 股票代码：601886 股票简称：江河集团 公告编号：临2023-026 公司独立董事对上述事项发表了事前认可意见和独立意见，内容详见公司同 ...

股票代码：601886 股票简称：江河集团 公告编号：临2023-028 江河创建集团股份有限公司 关于全资子公司对外提供阶段性担保的公告 本公司及董事会全体成员保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实、准确和完整承担个别及连带责任。 重要内容提示: （二）本次担保事项履行的内部决策程序 公司于 2023 年 9 月 1 日召开第六届董事会第十次会议审议通过了《关于全 资子公司对外提供阶段性担保的议案》，独立董事对该议案发表了同意的独立意 见，该议案尚需提交公司股东大会审议，提请股东大会授权公司董事长或董事长 指定人员在上述担保额度内办理担保相关手续，并签署相关法律文件。 二、被担保人基本情况 一、担保情况概述 （一）背景及担保基本情况 江河创建集团股份有限公司(下称"公司")全资子公司广州江河幕墙制造有 限公司（下称"广州子公司"）为承担公司在珠三角地区及海外市场幕墙加工生 产任务的工厂主体，随着公司在珠三角地区及海外业务规模的不断增加，原有广 州新塘工厂已不能满足自身发展需要，需要建设新工厂以满足当前生产经营需求， 为此广州子公司通过公开招牌挂方式在广州市增城区取得了工 ...

Financial Performance - The company reported a significant increase in revenue for the first half of 2023, with a total revenue of RMB 1.2 billion, representing a year-on-year growth of 15%[12]. - The company's operating revenue for the first half of 2023 reached ¥8,849,058,547.57, representing a 14.30% increase compared to the same period last year[19]. - Net profit attributable to shareholders for the same period was ¥292,548,747.75, a 42.03% increase year-on-year[20]. - The company achieved a revenue of approximately 8.849 billion CNY, representing a year-on-year growth of 14.3%, with the construction decoration segment contributing 8.317 billion CNY and the healthcare segment contributing 532 million CNY[55]. - The total profit for the period was approximately ¥405.09 million, reflecting a 39.98% increase compared to the previous year[74]. - The company reported a net profit of 15,159.49 million RMB from Jianghe Curtain Wall, which is 100% owned by the company[89]. - The company reported a net loss of CNY 22,660,041.20 for the first half of 2023, which is an improvement compared to a loss of CNY 75,205,634.81 in the same period last year[162]. Market Expansion and Strategy - The company has set a revenue target of RMB 2.5 billion for the full year 2023, which would require a growth of 20% in the second half of the year[12]. - The company is expanding its market presence in Southeast Asia, with plans to enter three new countries by the end of 2023, aiming for a market share increase of 10% in these regions[12]. - The company is actively expanding its market presence in the photovoltaic sector, leveraging its expertise in curtain wall technology[58]. - The company established an export division to promote international business development, focusing on curtain wall products including photovoltaic curtain walls for markets in Australia, America, and the Middle East[61]. Product Development and Innovation - New product development includes the launch of a solar energy integration system, which is expected to contribute an additional RMB 300 million in revenue by the end of 2023[12]. - The company has added 77 new patents in the reporting period, enhancing its technological capabilities in the curtain wall and photovoltaic building sectors[40]. - The company has developed a roof photovoltaic building integration system, showcasing its innovation in the photovoltaic construction sector[42]. - The company is investing RMB 100 million in research and development for new technologies in the construction sector, aiming to improve efficiency and reduce costs[12]. Financial Position and Cash Flow - The company maintains a strong cash position with cash reserves of RMB 800 million, providing flexibility for future investments and acquisitions[12]. - The net cash flow from operating activities was -¥1,251,007,446.87, showing an improvement from -¥2,008,521,478.64 in the previous year[20]. - The company reported a significant improvement in cash flow, with net cash flow from operating activities at -1.251 billion CNY, an increase of 758 million CNY compared to the same period last year[56]. - The ending cash and cash equivalents balance as of June 30, 2023, was 2,688,890,314.62 RMB, up from 2,137,861,782.89 RMB at the end of June 2022, representing an increase of about 25.8%[156]. Risks and Challenges - The company has identified potential risks including market competition and regulatory changes, which could impact future performance[12]. - The healthcare sector is facing challenges due to increased competition and market pressures, impacting the growth of private ophthalmology hospitals[29]. - The company faces risks related to policy changes in the construction decoration industry, particularly if regulations expand to public buildings, potentially impacting business development[90]. - The macroeconomic cycle poses a risk, as a slowdown in national economic growth could shrink market demand for construction decoration services, adversely affecting business expansion[91]. Shareholder and Equity Information - The total number of common shareholders as of the end of the reporting period is 18,189[128]. - The largest shareholder, Beijing Jianghe Source Holdings Co., Ltd., holds 315,645,200 shares, representing 27.86% of the total shares[130]. - The total equity attributable to the parent company at the end of the reporting period was CNY 7,985,343,283.65, an increase from CNY 7,622,362,427.72 at the beginning of the year[163]. Legal and Compliance Matters - The company has no significant litigation or arbitration matters during the reporting period[115]. - The company has previously recognized potential losses related to the case and does not expect further losses in the future[116]. - The company is currently involved in a lawsuit for unpaid project funds amounting to ¥102,696,260.10, with the case under review[117]. Corporate Governance - The board of directors has confirmed that there are no non-operational fund occupations by controlling shareholders, ensuring financial integrity[12]. - The company has committed to not engaging in any competitive business with Jianghe Group and its subsidiaries, ensuring strict adherence to this commitment[112].

证券代码：601886 证券简称：江河集团 公告编号：临 2023-025 江河创建集团股份有限公司 关于召开 2023 年半年度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 会议召开时间：2023 年 09 月 21 日(星期四) 下午 16:00-17:00 会 议 召 开 地 点 ： 上海证券 交 易 所 上 证 路 演 中 心 （ 网 址 ： https://roadshow.sseinfo.com/） 投资者可于 2023 年 09 月 14 日(星期四) 至 09 月 20 日(星期三)16:00 前 登录上证路演中心网站首页点击"提问预征集"栏目或通过公司邮箱 ir@jangho.com 进行提问。公司将在说明会上对投资者普遍关注的问题进行回 答。 江河创建集团股份有限公司（以下简称"公司"）已于 2023 年 8 月 29 日发 布公司 2023 年半年度报告，为便于广大投资者更全面深入地了解公司 2023 年半 年度经营成果、财务状况，公司计划于 2023 年 09 月 2 ...

Financial Performance - The company's operating revenue for Q1 2023 was CNY 3,419,268,950.09, representing a 3.99% increase compared to CNY 3,288,101,155.67 in the same period last year[4] - Net profit attributable to shareholders for Q1 2023 was CNY 163,558,009.90, a significant increase of 76.37% from CNY 91,489,289.02 in the previous year[4] - Basic and diluted earnings per share for Q1 2023 were both CNY 0.14, reflecting a 75.00% increase from CNY 0.08 in the same period last year[5] - The weighted average return on equity increased to 2.55% in Q1 2023, up by 1.09 percentage points from 1.44% in the previous year[5] - The company reported a 10.19% increase in net profit attributable to shareholders after deducting non-recurring gains and losses, amounting to CNY 144,891,078.72[4] - Net profit for Q1 2023 reached approximately ¥183.47 million, representing a 76.7% increase from ¥103.77 million in Q1 2022[18] - Total comprehensive income for Q1 2023 was approximately ¥151.49 million, compared to ¥59.23 million in Q1 2022, indicating strong growth[19] Assets and Liabilities - The total assets at the end of Q1 2023 were CNY 25,652,578,378.68, a decrease of 4.79% from CNY 26,931,897,665.21 at the end of the previous year[5] - As of March 31, 2023, the total assets of Jianghe Creation Group Co., Ltd. amounted to CNY 25,652,578,378.68, a decrease from CNY 26,944,243,375.12 at the end of 2022, representing a decline of approximately 4.8%[14] - The total current assets decreased to CNY 20,800,771,261.22 from CNY 22,138,783,071.51, indicating a reduction of about 6.0%[14] - The total liabilities decreased to CNY 17,883,502,652.98 from CNY 19,321,880,947.40, which is a reduction of about 7.4%[15] - The total current liabilities decreased to CNY 17,020,748,456.22 from CNY 18,578,545,760.19, indicating a reduction of about 8.4%[15] - The company's non-current liabilities increased to CNY 862,754,196.76 from CNY 743,335,187.21, which is an increase of approximately 16.0%[15] Cash Flow - The net cash flow from operating activities for Q1 2023 was CNY -1,049,827,760.63, an improvement from CNY -1,913,845,338.02 in the same period last year[5] - Cash inflow from operating activities in Q1 2023 was approximately ¥4.30 billion, an increase from ¥4.09 billion in Q1 2022[20] - The cash outflow from investing activities in Q1 2023 was 146,699,437.42, significantly lower than 439,509,294.10 in Q1 2022, reflecting a strategic reduction in investment spending[21] - The company reported a net cash flow from investing activities of 26,554,420.06 in Q1 2023, a substantial increase from 1,418,939.89 in Q1 2022[21] - The company’s net increase in cash and cash equivalents for Q1 2023 was -1,054,040,009.23, an improvement from -1,669,835,948.84 in Q1 2022, reflecting better cash management[22] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 21,534[10] - The largest shareholder, Beijing Jianghe Source Holdings Co., Ltd., held 27.86% of the shares, with 315,645,200 shares pledged[11] Other Financial Metrics - The company's cash and cash equivalents were reported at CNY 3,076,857,213.38, down from CNY 4,160,784,089.41, reflecting a decrease of approximately 26.0%[13] - The company's accounts receivable decreased to CNY 10,622,975,274.18 from CNY 11,383,252,002.72, indicating a decline of approximately 6.7%[13] - The inventory increased to CNY 1,157,222,622.76 from CNY 1,027,053,117.89, reflecting an increase of about 12.7%[14] - Research and development expenses for Q1 2023 were approximately ¥91.70 million, a slight decrease of 3.0% from ¥94.89 million in Q1 2022[17] - The company reported a significant increase in investment income, totaling approximately ¥3.42 million in Q1 2023, compared to ¥20.85 million in Q1 2022[17] - The company experienced a decrease in financial expenses, which were approximately ¥46.70 million in Q1 2023, down from ¥58.73 million in Q1 2022[17] - Other comprehensive income after tax for Q1 2023 was approximately -¥31.98 million, an improvement from -¥44.53 million in Q1 2022[18]

Financial Performance - The company's operating revenue for 2022 was CNY 18,056,403,834, a decrease of 13.15% compared to CNY 20,789,389,103.66 in 2021[23]. - The net profit attributable to shareholders for 2022 was CNY 489,069,415.91, a significant recovery from a loss of CNY 1,007,130,382.85 in 2021[23]. - The basic earnings per share for 2022 was CNY 0.43, compared to a loss of CNY 0.89 per share in 2021[25]. - The total assets at the end of 2022 were CNY 26,931,897,665.21, down 4.43% from CNY 28,178,830,167.26 in 2021[24]. - The cash flow from operating activities for 2022 was a negative CNY 152,645,601.86, a decline of 113.84% from CNY 1,102,962,030.97 in 2021[24]. - The company reported non-recurring gains of CNY 288,406,517.14 in 2022, primarily from the disposal of non-current assets[28]. - The weighted average return on equity for 2022 was 7.73%, a recovery from -13.44% in 2021[25]. - The company achieved quarterly revenues of CNY 5,758,763,469.03 in Q4 2022, marking a significant increase compared to previous quarters[26]. - The net profit attributable to shareholders in Q3 2022 was CNY 243,131,895.62, showing strong performance in that quarter[26]. - The company reported a significant increase in investment income, rising by 345.93% to RMB 324 million[76]. - The company’s operating cash flow net amount decreased by 113.84% to RMB -153 million due to reduced project payments[76]. - The company achieved a total revenue of RMB 18.06 billion, a year-on-year decrease of 13.15%[74]. - The construction decoration segment generated revenue of RMB 17.08 billion, down 13.86% year-on-year[74]. - The healthcare segment reported revenue of RMB 961 million, an increase of 1.85% year-on-year[74]. - The net profit for the company was RMB 547 million, with a net profit attributable to shareholders of RMB 489 million[74]. Dividend Distribution - The company plans to distribute a cash dividend of 0.2 RMB per 10 shares based on a total share capital of 1,133,002,060 shares as of March 28, 2023[6]. - The company distributed a cash dividend of 1 yuan (including tax) for every 10 shares, totaling 113.3 million yuan in cash dividends during the reporting period[42]. - The company maintains a high dividend payout ratio of 66.29%, having distributed approximately 2.267 billion yuan in cash dividends since its listing[42]. - In 2022, the company implemented a cash dividend policy, distributing ¥113.30 million to shareholders, with a dividend of ¥1 per 10 shares[182]. Risk Management - The company faces significant risks including policy risks and market competition risks, which are detailed in the report[8]. - The company emphasizes the importance of risk awareness in its forward-looking statements[7]. - The company has implemented measures to mitigate risks from raw material price fluctuations, but significant increases in material costs could adversely affect profitability[135]. - The investment in the production line for unconventional photovoltaic modules may face risks due to local policies, industry trends, and raw material price fluctuations, potentially impacting operational efficiency[137]. - The healthcare business is significantly influenced by local medical management systems and insurance policies, with ongoing reforms creating uncertainty in policy implementation[138]. - The company is actively exploring business models that align with regional healthcare policies to mitigate policy risks in the medical sector[138]. - The healthcare industry faces inherent medical risks due to individual patient differences and varying levels of medical expertise, which the company aims to manage through strict adherence to international medical control systems[139]. - The expansion of the healthcare business may encounter management risks if the company fails to replicate advanced management practices from overseas effectively[141]. - The company relies heavily on high-quality technical and management talent in the healthcare sector, facing potential talent shortages that could hinder business expansion[142]. - The overseas healthcare business, primarily concentrated in Australia, is subject to economic, political, and cultural risks that could adversely affect operations[143]. Corporate Governance - The company has established a governance structure compliant with relevant laws, ensuring the proper functioning of the shareholders' meeting, board of directors, and supervisory board[145]. - The board of directors consists of nine members, including three independent directors, ensuring a balanced governance approach[148]. - The company maintains transparency in information disclosure, ensuring all shareholders have equal access to information, enhancing operational transparency[153]. - The company emphasizes investor relations management, implementing a system to communicate effectively with investors through various channels[154]. - The company maintains independence from its controlling shareholders in terms of assets, personnel, finance, and operations[154]. - The company has established specialized committees under the board, including audit, nomination, remuneration, and strategy committees[171]. - The internal audit report indicated that the company's internal controls were functioning effectively, with no significant deficiencies identified[173]. Market Expansion and Strategy - The company is focused on expanding its market through new product development and technological advancements[12]. - The company plans to focus on market expansion and new product development in the upcoming fiscal year[27]. - The company is actively expanding its architectural decoration business, focusing on high-end projects such as office buildings, hotels, and commercial complexes[49]. - The company has undertaken several landmark projects, including the renovation of the Beijing Workers' Stadium and the Hangzhou Hang Lung Plaza, receiving positive feedback from clients[50]. - The company is accelerating the development of its photovoltaic building integration business, with a new production base for flexible photovoltaic components set to commence operations in 2023[129]. - The company intends to enhance its interior decoration capabilities and expand into high-end markets in Southeast Asia, particularly in Singapore and Malaysia[130]. - The company plans to focus on its core business in the construction decoration sector, with a target of achieving a bidding amount of 26 billion yuan in 2023[130]. - The company aims to expand its domestic and international market share in the curtain wall business, leveraging its leading position and technological advantages[128]. Research and Development - The company received 96 patent authorizations during the reporting period, including 13 invention patents and 83 utility model patents[38]. - Total R&D expenditure amounted to ¥525,104,039.17, representing 2.91% of total revenue[85]. - The company employed 1,621 R&D personnel, accounting for 17.17% of the total workforce[86]. - Research and development expenses increased by 10%, totaling 100 million, to support new technology initiatives[162]. Operational Efficiency - The company has established a comprehensive internal control system, which was audited and received a standard unqualified opinion[188]. - The company continues to enhance its internal management and operational efficiency through a matrix management approach and regular operational meetings[187]. - The company has not invested any funds in environmental protection during the reporting period, indicating no significant environmental obligations[190]. Social Responsibility - Total charitable contributions amounted to CNY 593,000, including CNY 306,000 in cash donations and CNY 287,000 in material donations[193]. - The company invested CNY 226,000 in poverty alleviation and rural revitalization projects, benefiting 350 individuals[193]. - The company has disclosed its 2022 annual social responsibility report on March 29, 2023[192].

重要内容提示： （http://roadshow.sseinfo.com） 投资者可于 2023 年 4 月 10 日（星期一）至 4 月 14 日（星期五）16:00 前登录上证路演中心网站首页点击"提问预征集"栏目或通过公司邮箱 ir@jangho.com 进行提问。公司将在业绩暨现金分红说明会上对投资者普 遍关注的问题进行回答。 江河创建集团股份有限公司（以下简称"公司"）于 2023 年 3 月 29 日披露 公 司 2022 年 年 度 报 告 ， 相 关 内 容 详 见 上 海 证 券 交 易 所 网 站 （http://www.sse.com.cn）。为便于广大投资者更全面深入地了解公司 2022 年 度经营成果、财务状况，公司计划于 2023 年 04 月 17 日 下午 15:00-16:30 举 行 2022 年度业绩暨现金分红说明会，就投资者关心的问题进行交流。 一、 说明会类型 股票代码：601886 股票简称：江河集团 公告编号：临2023-012 江河创建集团股份有限公司 关于召开 2022 年度业绩暨现金分红说明会的公告 本公司及董事会全体成员保证本公告内容不存在任何虚假记载、误 ...

Financial Performance - The company's operating revenue for Q3 2022 was ¥4,555,850,530.69, a decrease of 17.27% compared to the same period last year[8]. - Net profit attributable to shareholders for Q3 2022 was ¥243,131,895.62, an increase of 67.86% year-on-year[8]. - Net profit attributable to shareholders after deducting non-recurring gains and losses was ¥46,041,132.79, a decrease of 59.31% compared to the same period last year[8]. - Basic earnings per share for Q3 2022 was ¥0.22, an increase of 69.23% year-on-year[9]. - The weighted average return on equity for Q3 2022 was 3.95%, an increase of 2.29 percentage points compared to the same period last year[9]. - Total operating revenue for Q3 2022 was CNY 12,297,640,364.97, a decrease from CNY 14,202,745,326.60 in the same period of 2021, representing a decline of approximately 13.4%[25]. - Net profit for Q3 2022 was CNY 452,255,047.71, compared to CNY 592,326,821.32 in Q3 2021, reflecting a decrease of approximately 23.7%[28]. - The total comprehensive income attributable to the parent company for Q3 2022 was CNY 108,216,585.32, down from CNY 637,868,601.39 in Q3 2021, reflecting a significant decline[29]. - Basic and diluted earnings per share for Q3 2022 were both CNY 0.40, a decrease from CNY 0.46 in Q3 2021[29]. - The company reported a total comprehensive income of CNY 43,521,189.81 for Q3 2022, significantly lower than CNY 712,911,015.78 in Q3 2021[29]. Assets and Liabilities - Total assets at the end of Q3 2022 were ¥26,721,402,927.18, a decrease of 5.17% compared to the end of the previous year[9]. - Total assets decreased from CNY 28.18 billion at the end of 2021 to CNY 26.72 billion as of September 30, 2022, representing a decline of approximately 5.2%[22]. - The company's total liabilities decreased to CNY 19,190,888,440.44 in Q3 2022 from CNY 20,506,823,479.39 in Q3 2021, a reduction of about 6.4%[25]. - The total equity attributable to shareholders at the end of Q3 2022 was ¥6,331,250,401.72, a slight decrease of 0.14% compared to the previous year[9]. - The total equity attributable to shareholders was CNY 6,331,250,401.72 in Q3 2022, slightly down from CNY 6,340,078,606.89 in Q3 2021, showing a marginal decrease of 0.1%[25]. Cash Flow - The net cash flow from operating activities for the year-to-date was -¥2,050,350,687.31[9]. - Net cash flow from operating activities for the first three quarters of 2022 was -CNY 2,050,350,687.31, compared to -CNY 1,509,444,145.73 in the same period of 2021, indicating a worsening cash flow situation[32]. - The net cash flow from investing activities was -CNY 32,680,448.64 for the first three quarters of 2022, an improvement from -CNY 895,495,045.50 in the same period of 2021[33]. - Net cash flow from financing activities was CNY 355,990,265.85 in the first three quarters of 2022, compared to -CNY 328,519,436.57 in the same period of 2021, showing a positive shift[33]. - Cash outflow from operating activities totaled CNY 14,721,505,745.13 in the first three quarters of 2022, a decrease from CNY 15,072,884,255.98 in the same period of 2021[32]. Shareholder Information - The company reported a total of 21,676 common shareholders at the end of the reporting period[17]. - The largest shareholder, Beijing Jianghe Source Holdings Co., Ltd., holds 27.86% of the shares, totaling 315,645,200 shares[17]. - The second-largest shareholder, Liu Zaiwang, owns 25.53% of the shares, amounting to 289,307,866 shares[17]. Research and Development - Research and development expenses for Q3 2022 were CNY 346,974,137.86, compared to CNY 388,227,709.96 in Q3 2021, indicating a decrease of approximately 10.6%[25]. Cash and Current Assets - Cash and cash equivalents decreased significantly from CNY 5.12 billion to CNY 3.00 billion, a decline of approximately 41.3%[20]. - Current assets decreased from CNY 22.36 billion at the end of 2021 to CNY 21.67 billion, a reduction of about 3.1%[22]. - The company's cash and cash equivalents decreased to CNY 1,133,002,060.00 in Q3 2022 from CNY 1,154,050,000.00 in Q3 2021, a decline of about 1.8%[25]. - The total cash and cash equivalents at the end of Q3 2022 were CNY 2,171,945,651.27, down from CNY 2,236,412,440.44 at the end of Q3 2021[33].